GleanMark

ADAC Trademark

ADAC is a USPTO trademark filed by Strike Pharma AB. Status: Registered.

Trademark Facts

MarkADAC
Serial Number79322105
Registration Number6970291
StatusRegistered
Filing Date2021-08-24
Registration Date2023-02-07
Mark TypeWord
Nice Classes001 (Chemicals), 005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT)
OwnerStrike Pharma AB
Attorney of RecordDonna J. Bunton
Prosecution Events29
Latest EventLIMG on 2026-04-16

Goods & Services

Chemicals for use in industry for production of antibodies and synthetic and natural peptides | Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology | Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes | Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies

Related